Last update 24 Jun 2024

Cholic Acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cholic acid (USAN), E-1000, G1JO-7801AE
+ [6]
Target
Mechanism
FXR agonists(Bile acid receptor FXR agonists)
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
RegulationOrphan Drug (EU)
Login to view First Approval Timeline

Structure

Molecular FormulaC24H40O5
InChIKeyBHQCQFFYRZLCQQ-OELDTZBJSA-N
CAS Registry81-25-4

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
disorder of bile acid and cholesterol metabolism
JP
RECMEDStartup
27 Mar 2023
Bile Acid Synthesis Defect
US
17 Mar 2015
Liver Diseases
US
17 Mar 2015
Peroxisomal Disorders
US
17 Mar 2015
Steatorrhea
US
17 Mar 2015
Zellweger Syndrome
US
17 Mar 2015
Bile Acid Synthesis Defect, Congenital, 1
EU
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 1
IS
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 1
LI
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 1
NO
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 2
EU
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 2
IS
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 2
LI
12 Sep 2013
Bile Acid Synthesis Defect, Congenital, 2
NO
12 Sep 2013
Inborn error in primary bile acid synthesis
EU
12 Sep 2013
Inborn error in primary bile acid synthesis
IS
12 Sep 2013
Inborn error in primary bile acid synthesis
LI
12 Sep 2013
Inborn error in primary bile acid synthesis
NO
12 Sep 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
12
vkpclmttxh(eauratwinn) = ttqjaeycxu lqmiimwtea (wognwpcrlo, xiwvohpfii - ttijiyekvt)
-
13 Dec 2023
Not Applicable
12
rnqzyliquj(mzdsbfciwd) = vooucxhhao qgrbrnlqbe (ipjjfdbkka )
Positive
30 Aug 2023
Phase 3
53
anqlanbsfc(nwuhidmaqk) = cftycpzsyv ytpgctbvlj (hwdxaflwgd, zrmkwmciqr - fzozdolwxw)
-
21 Aug 2020
Phase 3
16
fleipbfejz(ccqomnhxnp) = xzrwsoajei hlegmrxvpr (ubbylkzocn, yljcgnkxce - hbbzisesvw)
-
09 Dec 2016
Phase 2
18
yrmkpxqgsf(yiajawzsug) = nigmuikwzc rdbrerbdkb (ltzvfzejvt, 9.4 - 19.0)
Negative
01 May 2013
Placebo
yrmkpxqgsf(yiajawzsug) = lsjryihizo rdbrerbdkb (ltzvfzejvt, 10.5 - 26.5)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free